You are in:Home/Publications/Evaluation of storage symptoms improvement and factors affecting, after relief of obstruction in patients with benign prostatic enlargement

Dr. Mohamed Abdel_rahman Alhefnawy :: Publications:

Title:
Evaluation of storage symptoms improvement and factors affecting, after relief of obstruction in patients with benign prostatic enlargement
Authors: Tarek Gharib, MD, PhD Amr Eldakhakhny, M.D. Hisham Alazaby, M.D. Mostafa Khalil, M.D. Khaled Elgamal, M.D. Mohamed Alhefnawy, M.D.
Year: 2022
Keywords: Not Available
Journal: Not Available
Volume: Not Available
Issue: Not Available
Pages: Not Available
Publisher: Not Available
Local/International: International
Paper Link: Not Available
Full paper Mohamed Abdel_rahman Alhefnawy_URol gold paper.pdf
Supplementary materials Not Available
Abstract:

Objectives: To evaluate the improvement of storage symptoms in accordance with voiding symptoms and assess the prognostic factors that influence the relief of storage symptoms after transurethral resection of the prostate (TURP). Methods: Between August 2017 to November 2019, 75 patients indicated for TURP were included in the study, we assessed the improvement of storage symptoms and factors that may influence storage symptoms persistence after TURP such as Age, Overactive bladder symptoms (OABS) score (Blaivas 2007) and Urodynamic parameters such as maximum flow rate (Q MAX), maximum cystometric capacity (MCC), bladder contractility index (BCI), phasic and terminal detrusor overactivity (DO). Assessment of patients was done before and six months after TURP by international prostate symptom score (IPSS), quality of life score (QLSS), OABSS (Blaivas score 2007), and urodynamic studies. Results: Mean age of the patients was 67.88±7.82 years. The patients with persistence of storage symptoms were significantly older 70.43±8.32 vs 67.04±7.49 respectively p-value = 0.022, also IPSS score was significantly higher in patients with resolution of symptoms (26.83±3.91 vs 24.35±3.68 p=0.017). Terminal D.O and Q max were significantly higher in patients with persistence of storage symptoms (26.3% and 8.1 vs 8.9% and 6 respectively). MCC was significantly higher in a patient with resolution vs persistence of storage symptoms (345.18±90.89 ml vs 242.16±72.73) respectively p=0.001 There was no significant difference between both groups regarding duration of symptoms, prostate size, prostatic specific antigen (PSA), QOL score, OABS score, and maximum detrusor pressure

Google ScholarAcdemia.eduResearch GateLinkedinFacebookTwitterGoogle PlusYoutubeWordpressInstagramMendeleyZoteroEvernoteORCIDScopus